ArticleNanotechnology In The Pandemic And What The Future Holds For RegulationEvery day, nanotechnology, the miniaturization of particles in the industrial and manufacturing process down to a billionth of a meter in size, ...United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleNew FDA Tip SheetThis is a great update regarding new FDA regulations concerning the supply of critical foods including infant formula and medical foods.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticlePersonalized Multiplex Test On MarketA multiplex test that can analyze tumors for over 200 genes is now available from Foundation Medicine Inc., the Wall Street Journal reported today.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticlePrivacy Issues In The Sharing Of Genetic Information 1 Oct 2014Low cost sequencing of a patient’s genome and advances in the interpretation of a patient’s genetic information is promised to transform the delivery of health care.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleProtecting Bees: The Buzz About A New VaccineBees and insects face diseases similar to humans, and American foulbrood poses a significant threat to bee colonies.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleRepositioning Of Nursing Homes To Alternative Models Of CareWhatever the future, it is reasonably likely that regulators will more carefully watch closure and repositioning projects to ensure access to SNF beds...United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleSafer And More Powerful Batteries – Dreamliner And PoliticalThe Wall Street Journal and other media are reporting that the National Transportation Safety Board is investigating microscopic "dendrite" formation as possible causes for the "dreamliner" lithium ion battery problems.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleSunny Levine Discusses Future Of Telemedicine On Podnosis PodcastFoley & Lardner LLP Senior Counsel Sunny Levine is interviewed on the latest episode of Podnosis, Fierce Healthcare's weekly podcast covering the biggest trends in health care, discussing...United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleSupreme Court Decides Myriad Case: Synthetic DNA Held Patentable & Implications For NanotechThe Supreme Court recently rendered its decision in the landmark Myriad case, holding that naturally occurring DNA segments are not patentable, but synthetic DNA segments are patent eligible based on the patent eligibility requirement of 35 U.S.C.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleThe Future Of Reproductive Health: Building & Investing In Post-Roe AmericaClaire Marblestone, will be a speaker at The Future of Reproductive Health: Building & Investing in Post-Roe America.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleUpdates With Materials Genome Initiative, $25M Grants Announced; Complex IP Issues?The Office of Science and Technology Policy (OSTP) recently announced updates with the Materials Genonme Initiative (MGI). $25M in grants are noted, and the awardees include universities, national laboratories, and private sector companies (e.g., GM). Collaboration continues to be a strong theme.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleU.S. Patent Office Issues Guidance To Examiners On Supreme Court's Myriad DecisionThe USPTO recently issued guidance to Examiners on how to apply the Myriad Supreme Court decision to applications under examination.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleUSC Announces Stem Cell CollaborationTreatment and prevention of heart failure are unmet medical needs in the United States. One in every eight deaths in the United States can be linked to this disease.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleUSPTO Imposes New Limits On Credit Card PaymentsAs announced on the USPTO website, as of June 30, 2012, there will be a daily limit of $49,999.99 for credit card accounts, but no daily limit for debit card accounts. United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleWe Look Forward To Seeing You At The Telehealth And The 2023 Medicare Physician Fee WebinarWe hope that you can join Foley Partners, Nathaniel Lacktman and T.J. Ferrante, at the Health Tech Nerds (HTN) member webinar on August 11, 2022.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
ArticleWhat The Department Of Justice's 2025 FCA Recoveries Signal For 2026: Health Care, Cyber, And CustomsThe DOJ and relators' bar continues to aggressively deploy the False Claims Act across a variety of subject areas, including health care, cybersecurity, and customs.United StatesFood, Drugs, Healthcare, Life SciencesFoley & Lardner LLP
VideoMidterm Elections: What Happens Now? (Video)During this presentation, Jason Kohout, co-chair of Foley's Family Office practice, and Scott Klug, public affairs director and co-chair of the Federal Public Affairs practice...United StatesGovernment, Public SectorFoley & Lardner LLP
ArticleVanessa Miller Discusses Solutions To The Demand For SemiconductorsFoley & Lardner LLP Partner Vanessa Miller was featured in the article, "Buyer Beware: Avoid These 3 Semiconductor Procurement Pitfalls," in Supply Chain Dive...United StatesGovernment, Public SectorFoley & Lardner LLP
ArticleGood News For Patentees: Five Years After KSR, New Case Reveals "Poster Child For Impermissable Hindsight Reasoning"The KSR Supreme Court decision on obviousness is now more that five years old (decision rendered April 30, 2007). United StatesIntellectual PropertyFoley & Lardner LLP
ArticleGuarding Against Conclusory Statements & Why It Matters Even More Under The New PTAB RulesA good practice is to have a fresh pair of eyes go through each sentence of the expert's declaration before filing and ask the question – is there support or evidence that can be added to back up that statement?United StatesIntellectual PropertyFoley & Lardner LLP